Child and parent

Drug improves symptoms of autism by targeting brain’s chemical messengers

27 January 2020

Bumetanide – a prescription drug for oedema (the build-up of fluid in the body) – improves some of the symptoms in young children with autism spectrum disorders and has no significant side effects, confirms a new study from researchers in China and the UK. Published today in Translational Psychiatry, the study demonstrates for the first time that the drug improves the symptoms by decreasing the ratio of the GABA to glutamate in the brain. GABA and glutamate are both neurotransmitters – chemical messengers that help nerve cells in the brain communicate.

Read More

Higher rates of post-natal depression among autistic mothers

15 January 2020

Autistic mothers are more likely to report post-natal depression compared to non-autistic mothers, according to a new study of mothers of autistic children carried out by researchers at the University of Cambridge. A better understanding of the experiences of autistic mothers during pregnancy and the post-natal period is critical to improving wellbeing. The results are published in Molecular Autism.

Read More

Women in STEM: Anna Chaplin

09 January 2020

Anna Chaplin is a PhD candidate in the Department of Psychiatry who studies the association between depression and cardiovascular health in young people. Here, she tells us about teaching herself to code, her department’s support of students, and putting your mental health first. 

Read More

Study identifies brain networks that play crucial role in suicide risk

02 December 2019

An international team of researchers has identified key networks within the brain which they say interact to increase the risk that an individual will think about – or attempt – suicide. Writing in Molecular Psychiatry, the researchers say that their review of existing literature highlights how little research has been done into one of the world’s major killers, particularly among the most vulnerable groups.

Read More

Pages